참고문헌
- Hogan SP, Rosenberg HF, Moqbel R, Phipps S, Foster PS, Lacy P, et al. Eosinophils: biological properties and role in health and disease. Clin Exp Allergy 2008;38:709-50. https://doi.org/10.1111/j.1365-2222.2008.02958.x
- The Global Initiative for Asthma. GINA report, global strategy for asthma management and prevention. Updated Dec. 2011 [Internet]. [place unknown]: The Global Initiative For Asthma; c2011. [cited 2011 Jun 21]. Available from: http://www.ginasthma.org/guidelinesgina- report-global-strategy-for-asthma.html.
- British Thoracic Society. 2008 British guideline on the management of asthma: a national clinical guideline. Updated Jun. 2009 [Internet]. London: British Thoracic Society; c2011 [cited 2011 Jun 21]. Available from: http://www.brit-thoracic.org.uk/guidelines/ asthma-guidelines.aspx.
- Crimi E, Spanevello A, Neri M, Ind PW, Rossi GA, Brusasco V. Dissociation between airway inflammation and airway hyperresponsiveness in allergic asthma. Am J Respir Crit Care Med 1998;157:4-9. https://doi.org/10.1164/ajrccm.157.1.9703002
- Parameswaran K, Pizzichini E, Pizzichini MM, Hussack P, Efthimiadis A, Hargreave FE. Clinical judgement of airway inflammation versus sputum cell counts in patients with asthma. Eur Respir J 2000;15:486-90. https://doi.org/10.1034/j.1399-3003.2000.15.10.x
- Pizzichini MM, Pizzichini E, Clelland L, Efthimiadis A, Pavord I, Dolovich J, et al. Prednisone-dependent asthma: inflammatory indices in induced sputum. Eur Respir J 1999;13:15-21. https://doi.org/10.1183/09031936.99.13101599
- Jatakanon A, Lim S, Barnes PJ. Changes in sputum eosinophils predict loss of asthma control. Am J Respir Crit Care Med 2000;161:64-72. https://doi.org/10.1164/ajrccm.161.1.9809100
- Venge P. Monitoring the allergic inflammation. Allergy 2004;59: 26-32. https://doi.org/10.1046/j.1398-9995.2003.00386.x
- Gleich GJ, Adolphson CR. The eosinophil and bronchial asthma: evidence for a critical role of eosinophils in pathophysiology. In: Sanderson CJ, editor., Interleukin-5: from molecule to drug target for asthma (lung biology in health disease). New York: Marcel Dekker, 1999:1-37.
- Kim KW, Lee KE, Kim ES, Song TW, Sohn MH, Kim KE. Serum eosinophil-derived neurotoxin (EDN) in diagnosis and evaluation of severity and bronchial hyperresponsiveness in childhood asthma. Lung 2007;185:97-103. https://doi.org/10.1007/s00408-006-0054-8
- Taniuchi S, Chihara J, Kojima T, Yamamoto A, Sasai M, Kobayashi Y. Serum eosinophil derived neurotoxin may reflect more strongly disease severity in childhood atopic dermatitis than eosinophil cationic protein. J Dermatol Sci 2001;26:79-82. https://doi.org/10.1016/S0923-1811(00)00151-1
- Wilson NM, Bridge P, Spanevello A, Silverman M. Induced sputum in children: feasibility, repeatability, and relation of findings to asthma severity. Thorax 2000;55:768-74. https://doi.org/10.1136/thorax.55.9.768
- Wojnarowski C, Roithner B, Koller DY, Halmerbauer G, Gartner C, Tauber E, et al. Lack of relationship between eosinophil cationic protein and eosinophil protein X in nasal lavage and urine and the severity of childhood asthma in a 6-month follow-up study. Clin Exp Allergy 1999;29: 926-32. https://doi.org/10.1046/j.1365-2222.1999.00586.x
- Gleich GJ, Adolphson CR. The eosinophilic leukocyte: structure and function. Adv Immunol 1986;39:177-253. https://doi.org/10.1016/S0065-2776(08)60351-X
- Venge P, Bystrom J, Carlson M, Hakansson L, Karawacjzyk M, Peterson C, et al. Eosinophil cationic protein (ECP): molecular and biological properties and the use of ECP as a marker of eosinophil activation in disease. Clin Exp Allergy 1999;29:1172-86. https://doi.org/10.1046/j.1365-2222.1999.00542.x
- Goto T, Morioka J, Inamura H, Yano M, Kodaira K, Igarashi Y, et al. Urinary eosinophil-derived neurotoxin concentrations in patients with atopic dermatitis: a useful clinical marker for disease activity. Allergol Int 2007;56:433-8. https://doi.org/10.2332/allergolint.O-07-489
- Koller DY, Halmerbauer G, Frischer T, Roithner B. Assessment of eosinophil granule proteins in various body fluids: is there a relation to clinical variables in childhood asthma? Clin Exp Allergy 1999;29:786-93. https://doi.org/10.1046/j.1365-2222.1999.00546.x
- Harrison AM, Bonville CA, Rosenberg HF, Domachowske JB. Respiratory syncytical virus-induced chemokine expression in the lower airways: eosinophil recruitment and degranulation. Am J Respir Crit Care Med 1999;159:1918-24. https://doi.org/10.1164/ajrccm.159.6.9805083
- Kim CK, Choi J, Kim HB, Callaway Z, Shin BM, Kim JT, et al. A randomized intervention of montelukast for post-bronchiolitis: effect on eosinophil degranulation. J Pediatr 2010;156:749-54. https://doi.org/10.1016/j.jpeds.2009.12.001
- Papadopoulos NG, Papi A, Meyer J, Stanciu LA, Salvi S, Holgate ST, et al. Rhinovirus infection up-regulates eotaxin and eotaxin-2 expression in bronchial epithelial cells. Clin Exp Allergy 2001;31: 1060-6. https://doi.org/10.1046/j.1365-2222.2001.01112.x
- Choi EH, Lee HJ, Yoo T, Chanock SJ. A common haplotype of interleukin- 4 gene IL4 is associated with severe respiratory syncytial virus disease in Korean children. J Infect Dis 2002;186: 1207-11. https://doi.org/10.1086/344310
- Parkin PC, Macarthur C, Saunders NR, Diamond SA, Winders PM. Development of a clinical asthma score for use in hospitalized children between 1 and 5 years of age. J Clin Epidemiol 1996;49: 821-5. https://doi.org/10.1016/0895-4356(96)00027-3
- Kim CK, Callaway Z, Fletcher R, Koh YY. Eosinophil-derived neurotoxin in childhood asthma: correlation with disease severity. J Asthma 2010;47:568-73. https://doi.org/10.3109/02770901003792833
- Kim CK, Kita H, Callaway Z, Kim HB, Choi J, Fujisawa T, et al. The roles of a Th2 cytokine and CC chemokine in children with stable asthma: potential implication in eosinophil degranulation. Pediatr Allergy Immunol 2010;21(4 Pt 2):e697-704. https://doi.org/10.1111/j.1399-3038.2010.01047.x
- Kim CK, Callaway Z, Kim DW, Kita H. Eosinophil degranulation is more important than eosinophilia in identifying asthma in chronic cough. J Asthma 2011;48:994-1000. https://doi.org/10.3109/02770903.2011.623335
피인용 문헌
- Omalizumab is effective in treating severe asthma in patients with severe cardiovascular complications and its effects on sCD200, d-dimer, CXCL8, 25-hydroxyvitamin D and IL-1β levels vol.13, pp.9, 2013, https://doi.org/10.1517/14712598.2013.819338
- Effects of omalizumab on eosinophil cationic peptide, 25-hydroxyvitamin-D, IL-1β and sCD200 in cases of Samter's syndrome: 36 months follow-up vol.35, pp.4, 2013, https://doi.org/10.3109/08923973.2013.811598
- Exhaled nitric oxide and nasal tryptase are associated with wheeze, rhinitis and nasal allergy in primary school children vol.19, pp.6, 2013, https://doi.org/10.3109/1354750x.2014.937362
- Eosinophil-Derived Neurotoxin (EDN/RNase 2) and the Mouse Eosinophil-Associated RNases (mEars): Expanding Roles in Promoting Host Defense vol.16, pp.12, 2013, https://doi.org/10.3390/ijms160715442
- Serum Levels of Eosinophil-Derived Neurotoxin: A Biomarker for Asthma Severity in Adult Asthmatics vol.11, pp.3, 2019, https://doi.org/10.4168/aair.2019.11.3.394
- Phenotypes of the inflammatory cells in the induced sputum from young children or infants with recurrent wheezing vol.85, pp.4, 2019, https://doi.org/10.1038/s41390-018-0268-5
- Analysis of the predicting factors of recurrent wheezing in infants vol.45, pp.1, 2013, https://doi.org/10.1186/s13052-019-0609-y
- Montelukast use over the past 20 years: monitoring of its effects and safety issues vol.63, pp.10, 2020, https://doi.org/10.3345/cep.2019.00325
- Comparison of serum eosinophil-derived neurotoxin levels between wheezing and non-wheezing groups in children with respiratory tract infection vol.57, pp.11, 2013, https://doi.org/10.1080/02770903.2019.1642349
- Eosinophil-derived neurotoxin: A biologically and analytically attractive asthma biomarker vol.16, pp.2, 2013, https://doi.org/10.1371/journal.pone.0246627
- Changes in Type 2 Biomarkers After Anti-IL5 Treatment in Patients With Severe Eosinophilic Asthma vol.13, pp.2, 2021, https://doi.org/10.4168/aair.2021.13.2.330